These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10636525)

  • 21. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction.
    Roffe C; Fletcher S; Woods KL
    Br Heart J; 1994 Feb; 71(2):141-5. PubMed ID: 8130021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era.
    Hohnloser SH; Klingenheben T; Zabel M; Schöpperl M; Mauss O
    J Am Coll Cardiol; 1999 Jun; 33(7):1895-902. PubMed ID: 10362190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
    Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
    J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
    Lancet; 1995 Mar; 345(8951):669-85. PubMed ID: 7661937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction.
    Parikka H; Toivonen L; Naukkarinen V; Tierala I; Pohjola-Sintonen S; Heikkilä J; Nieminen MS
    Eur Heart J; 1999 Jan; 20(2):111-20. PubMed ID: 10099907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intravenous magnesium sulphate in acute myocardial infarction.
    Fitzsimmons L; Verderber A; Shively M
    J Cardiovasc Nurs; 1993 Oct; 8(1):80-3. PubMed ID: 8106898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
    Eur Heart J; 2000 Sep; 21(18):1537-46. PubMed ID: 10973768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of thrombolytic therapy on the prevalence of ventricular late potentials in patients after myocardial infraction].
    Swiatowiec A; Dłuzniewski M; Mamcarz A; Kuch M
    Pol Arch Med Wewn; 2003 Dec; 110(6):1423-9. PubMed ID: 15052937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of thrombolytic therapy on short- and long-term cardiac autonomic activity in patients with acute myocardial infarction.
    Chen CK; Liou YM; Lee WL; Liu JR; Cheng HJ; Yang DY; Hu WH; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Dec; 58(6):392-9. PubMed ID: 9068205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G
    J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
    Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.
    Van de Werf F; Janssens L; Brzostek T; Mortelmans L; Wackers FJ; Willems GM; Heidbüchel H; Lesaffre E; Scheys I; Collen D
    J Am Coll Cardiol; 1993 Aug; 22(2):407-16. PubMed ID: 8335810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality.
    Smith LF; Heagerty AM; Bing RF; Barnett DB
    Int J Cardiol; 1986 Aug; 12(2):175-83. PubMed ID: 2427458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.
    Quintana M; Hjemdahl P; Sollevi A; Kahan T; Edner M; Rehnqvist N; Swahn E; Kjerr AC; Näsman P;
    Eur J Clin Pharmacol; 2003 May; 59(1):1-9. PubMed ID: 12743668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of K+ and Mg2+ in treatment of acute myocardial infarct].
    Kunert M; Scheuble L; Stolzenburg H; Gülker H
    Herz; 1997 Jun; 22 Suppl 1():63-72. PubMed ID: 9333594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of intravenous administration of SO4Mg in the acute phase of myocardial infarct].
    Pereira D; Pereira TG; Rabaçal C; Carvalho E; Linder J; Afonso JS; Pereira JN; Halpern MJ; Fernandes JS
    Rev Port Cardiol; 1990 Mar; 9(3):205-10. PubMed ID: 2390281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators.
    Flather M; Pipilis A; Collins R; Budaj A; Hargreaves A; Kolettis T; Jacob A; Millane T; Fitzgerald L; Cedro K
    Eur Heart J; 1994 May; 15(5):608-19. PubMed ID: 8055999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.